Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: McNabb Brothers who wrote (5611)	9/16/1998 12:24:00 PM
From: Linda Kaplan	Read Replies (1) \| Respond to of 7041

Hank, I'm not sure I understand the question? I think the company has a bleak future so I'd short it or buy long range puts. Assuming that application is going to be considered, then it will be a good ten months before anything will happen with the FDA and I think there's a good chance that Vasomax will not be approved by the FDA, because it's not a drug that is very effective, in my opinion. And it will have trouble competing with Viagra, which will have had the market a few years by the time Vasomax is approved, if it ever is approved. During these ten months, what can happen for Vasomax? Viagra also has been approved ahead of them everywhere they are applying now, and Viagra is a US approved drug while Vasomax isn't. I see the stock price eroding after a possible runup now (on the basis of a payment from SGP, which SGP would possibly be giving to ZONA if the app is passed by FDA this week). After this runup I just imagine the stock price will mostly be eroding, barring any fabulous news, of course. And what fabulous news can ZONA have? So I'm hoping for a runup to 20 or so if SGP gives them another milestone and that would be an optimal opportunity for shorting some shares or buying some puts. But here is a good short, too, IMO. (I see you're on the AMZN thread. I've got some puts. Are you long?) Linda